Protriptyline improves spatial memory and reduces oxidative damage by regulating NFκB-BDNF/CREB signaling axis in streptozotocin-induced rat model of Alzheimer's disease
- PMID: 33422534
- DOI: 10.1016/j.brainres.2020.147261
Protriptyline improves spatial memory and reduces oxidative damage by regulating NFκB-BDNF/CREB signaling axis in streptozotocin-induced rat model of Alzheimer's disease
Abstract
Antidepressants are well known to exert their role via upregulation of brain derived neurotrophic factor (BDNF). BDNF has been reported to exerts its neuroprotective effect in rodent and primate models as well as in patients of Alzheimer's disease (AD). The aim of our study was to evaluate the effect of protriptyline (PRT), a tricyclic antidepressant, in streptozotocin (STZ)- induced rat model of AD. Total 10 µl of STZ was injected into each ventricle (1 mg/kg). PRT (10 mg/kg, i.p.) treatment was started 3-day post STZ administration and continued till 21 days. We found that STZ treatment significantly increased pTau, Aβ42 and BACE-1 expression, oxidative stress and neurodegeneration in hippocampus and cortex of adult rats. STZ induced impairment in spatial learning and retention memory was associated with increased NFκB and reduced CREB and BDNF expression in cortex and hippocampus. Interestingly, PRT treatment significantly reduced pTau, Aβ42 and BACE-1 levels, neurodegeneration, oxidative stress and glial activation, contributing to the improved spatial learning and retention memory in STZ treated rats. Moreover, PRT treatment significantly improved p-ERK/ERK ratio and enhanced BDNF and CREB levels by reducing NFκB and GFAP expression in STZ treated rats. Our data suggest that impaired NFκB and CREB signaling potentially contribute in AD pathogenesis by elevating oxidative stress and neuroinflammation mediated neurodegeneration. Our study has established protriptyline as a multi target molecule in pre-clinical model of AD and further investigations on PRT like molecules could pave way for further development of effective new treatments in neurodegenerative disorders.
Keywords: Alzheimer’s disease; Antidepressant; BDNF; Memory; Oxidative stress; Protriptyline.
Copyright © 2021 Elsevier B.V. All rights reserved.
Similar articles
-
S-Nitrosoglutathione Attenuates Oxidative Stress and Improves Retention Memory Dysfunctions in Intra-Cerebroventricular-Streptozotocin Rat Model of Sporadic Alzheimer's Disease via Activation of BDNF and Nuclear Factor Erythroid 2-Related Factor-2 Antioxidant Signaling Pathway.Neuropsychobiology. 2024;83(2):101-113. doi: 10.1159/000538348. Epub 2024 May 14. Neuropsychobiology. 2024. PMID: 38744261
-
Arbutin reduces cognitive deficit and oxidative stress in animal model of Alzheimer's disease.Int J Neurosci. 2019 Nov;129(11):1145-1153. doi: 10.1080/00207454.2019.1638376. Epub 2019 Jul 19. Int J Neurosci. 2019. PMID: 31251091
-
Effects of levothyroxine on learning and memory deficits in a rat model of Alzheimer's disease: the role of BDNF and oxidative stress.Drug Chem Toxicol. 2020 Jan;43(1):57-63. doi: 10.1080/01480545.2018.1481085. Epub 2018 Jun 21. Drug Chem Toxicol. 2020. PMID: 29927658
-
Roflumilast Reduces Pathological Symptoms of Sporadic Alzheimer's Disease in Rats Produced by Intracerebroventricular Streptozotocin by Inhibiting NF-κB/BACE-1 Mediated Aβ Production in the Hippocampus and Activating the cAMP/BDNF Signalling Pathway.Neurotox Res. 2022 Apr;40(2):432-448. doi: 10.1007/s12640-022-00482-x. Epub 2022 Feb 22. Neurotox Res. 2022. Retraction in: Neurotox Res. 2024 Jul 15;42(4):34. doi: 10.1007/s12640-024-00713-3. PMID: 35192144 Retracted.
-
Environmental Toxins and Alzheimer's Disease: a Comprehensive Analysis of Pathogenic Mechanisms and Therapeutic Modulation.Mol Neurobiol. 2024 Jun;61(6):3657-3677. doi: 10.1007/s12035-023-03805-x. Epub 2023 Nov 25. Mol Neurobiol. 2024. PMID: 38006469 Review.
Cited by
-
Canagliflozin Mitigated Cognitive Impairment in Streptozotocin-Induced Sporadic Alzheimer's Disease in Mice: Role of AMPK/SIRT-1 Signaling Pathway in Modulating Neuroinflammation.J Neuroimmune Pharmacol. 2024 Jul 29;19(1):39. doi: 10.1007/s11481-024-10140-y. J Neuroimmune Pharmacol. 2024. PMID: 39073453
-
Combined Donepezil with Astaxanthin via Nanostructured Lipid Carriers Effective Delivery to Brain for Alzheimer's Disease in Rat Model.Int J Nanomedicine. 2023 Jul 27;18:4193-4227. doi: 10.2147/IJN.S417928. eCollection 2023. Int J Nanomedicine. 2023. PMID: 37534058 Free PMC article.
-
Intermittent theta burst stimulation attenuates oxidative stress and reactive astrogliosis in the streptozotocin-induced model of Alzheimer's disease-like pathology.Front Aging Neurosci. 2023 May 18;15:1161678. doi: 10.3389/fnagi.2023.1161678. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37273654 Free PMC article.
-
Effect of gastrodin against cognitive impairment and neurodegeneration in APP/PS1 mice via regulating gut microbiota-gut-brain axis.Exp Brain Res. 2023 Jun;241(6):1661-1673. doi: 10.1007/s00221-023-06632-7. Epub 2023 May 18. Exp Brain Res. 2023. PMID: 37199774
-
Near-infrared light reduces glia activation and modulates neuroinflammation in the brains of diet-induced obese mice.Sci Rep. 2022 Jun 27;12(1):10848. doi: 10.1038/s41598-022-14812-8. Sci Rep. 2022. PMID: 35761012 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous